Prognostic value of PSMA PET/CT in prostate cancer
Prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein expressed in
the majority of prostate cancer (PCa). PSMA has an enzymatic function that makes metabolic …
the majority of prostate cancer (PCa). PSMA has an enzymatic function that makes metabolic …
PSMA PET/CT in castration-resistant prostate cancer: myth or reality?
L Urso, L Filippi, A Castello, MC Marzola… - Journal of Clinical …, 2023 - mdpi.com
Background: prostate-specific membrane antigen (PSMA) ligand PET has been recently
incorporated into international guidelines for several different indications in prostate cancer …
incorporated into international guidelines for several different indications in prostate cancer …
[HTML][HTML] SPECT/CT, PET/CT, and PET/MRI for response assessment of bone metastases
N Zamani-Siahkali, SA Mirshahvalad, A Farbod… - Seminars in Nuclear …, 2024 - Elsevier
Recent developments in hybrid SPECT/CT systems and the use of cadmium-zinc-telluride
(CZT) detectors have improved the diagnostic accuracy of bone scintigraphy. These …
(CZT) detectors have improved the diagnostic accuracy of bone scintigraphy. These …
Correlation of [68Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients
EF Giunta, P Caroli, E Scarpi, A Altavilla… - European Journal of …, 2024 - Springer
Purpose to assess the utility of response monitoring to enzalutamide by using [68Ga] Ga-
PSMA PET in mCRPC patients treated with enzalutamide as first-line therapy. Methods …
PSMA PET in mCRPC patients treated with enzalutamide as first-line therapy. Methods …
[HTML][HTML] Prognostic Role of PSMA-Targeted Imaging in Metastatic Castration-Resistant Prostate Cancer: An Overview
M Caracciolo, A Castello, M Castellani, M Bartolomei… - Biomedicines, 2024 - mdpi.com
Objectives: Prostate-specific membrane antigen (PSMA) positron emission
tomography/computed tomography (PET/CT) has gained a primary role in prostate cancer …
tomography/computed tomography (PET/CT) has gained a primary role in prostate cancer …
[HTML][HTML] Analysis of Molecular Imaging Biomarkers Derived from [18F]FDG PET/CT in mCRPC: Whole-Body Total Lesion Glycolysis (TLG) Predicts Overall Survival in Patients Undergoing …
C Burgard, F Khreish, L Dahlmanns, A Blickle… - Cancers, 2024 - mdpi.com
Abstract Background/Objectives: The augmentation of [177Lu] Lu-PSMA-617 radioligand
therapy by alpha emitting [225Ac] Ac-PSMA-617, known as the tandem therapy concept, is a …
therapy by alpha emitting [225Ac] Ac-PSMA-617, known as the tandem therapy concept, is a …
Deep learning–based whole-body characterization of prostate cancer lesions on [68Ga]Ga-PSMA-11 PET/CT in patients with post-prostatectomy recurrence
B Huang, Q Yang, X Li, Y Wu, Z Liu, Z Pan… - European Journal of …, 2024 - Springer
Purpose The automatic segmentation and detection of prostate cancer (PC) lesions
throughout the body are extremely challenging due to the lesions' complexity and variability …
throughout the body are extremely challenging due to the lesions' complexity and variability …
Should new organ involvement be included in Response Evaluation Criteria in PSMA Imaging?
İ Kaplan, H Kömek, C Can, N Akdeniz, Y Güzel… - Annals of Nuclear …, 2024 - Springer
Purpose The current study is intended to investigate the effect of new organ involvement on
overall survival (OS) and modify the Response Evaluation Criteria in PSMA Imaging …
overall survival (OS) and modify the Response Evaluation Criteria in PSMA Imaging …
Dual-Tracer 18F-FDG and 68Ga-PSMA PET/CT Imaging of Heterogeneous Phenotypes of Metastatic Castration-Resistant Prostate Cancer for Predicting Response to …
L Bian, P Li, X Wang, Y Zuo, X Liu, L Bai… - Clinical Nuclear …, 2025 - journals.lww.com
Clinical Nuclear Medicine Log in or Register Get new issue alertsGet alerts Subscribe to
journal Secondary Logo Journal Logo Advanced Search Toggle navigation Register Login …
journal Secondary Logo Journal Logo Advanced Search Toggle navigation Register Login …
Automated Whole-Body Tumor Segmentation and Prognosis of Cancer on PET/CT
KH Leung - Proceedings of the SC'23 Workshops of The …, 2023 - dl.acm.org
Automatic characterization of malignant disease is an important clinical need to facilitate
early detection and treatment of cancer. A deep semi-supervised transfer learning approach …
early detection and treatment of cancer. A deep semi-supervised transfer learning approach …